Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (101-110 of 270) with videos related to

Pageof 27
Sort By:
World Journal of Gastroenterology|December 17, 2009
Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complicationsAngel Lanas, Juan-V Esplugues, Javier Zapardiel, et al.
Current Medical Research and Opinion|November 6, 2020
The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain facultyStephen B McMahon, Paul Dargan, Angel Lanas, et al.
Gastroenterologia Y Hepatologia|May 17, 2015
Colonic diverticular disease. Treatment and preventionCarla J Gargallo Puyuelo, Federico Sopeña, Angel Lanas Arbeloa
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2011
Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysisAngel Lanas, Ping Wu, Jennie Medin, et al.
Gastroenterologia Y Hepatologia|June 21, 2011
[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?]Rubén Casado-Arroyo, María Muñoz-Villalenguas, Angel Lanas Arbeloa
Gastroenterologia Y Hepatologia|November 26, 2009
[Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study]Angel Lanas, Maria Muñoz, Maria Caballero Correa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 22, 2015
Reply: To PMID 25460554Angel Lanas, Patricia Carrera, Luis Bujanda, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2003
Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugsAngel Lanas, Pedro Serrano, Eduardo Bajador, et al.
Expert Review of Clinical Pharmacology|November 26, 2011
Managing the adverse effects of nonsteroidal anti-inflammatory drugsPaola Patrignani, Stefania Tacconelli, Annalisa Bruno, et al.
The Journal of Pharmacy and Pharmacology|December 15, 2017
Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulationsIngvar Bjarnason, Ozgur Sancak, Anne Crossley, et al.
Pageof 27

Showing results (101-110 of 270) with videos related to

Sort By:
Pageof 27
World Journal of Gastroenterology|December 17, 2009
Education-based approach to addressing non-evidence-based practice in preventing NSAID-associated gastrointestinal complicationsAngel Lanas, Juan-V Esplugues, Javier Zapardiel, et al.
Current Medical Research and Opinion|November 6, 2020
The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain facultyStephen B McMahon, Paul Dargan, Angel Lanas, et al.
Gastroenterologia Y Hepatologia|May 17, 2015
Colonic diverticular disease. Treatment and preventionCarla J Gargallo Puyuelo, Federico Sopeña, Angel Lanas Arbeloa
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2011
Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysisAngel Lanas, Ping Wu, Jennie Medin, et al.
Gastroenterologia Y Hepatologia|June 21, 2011
[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?]Rubén Casado-Arroyo, María Muñoz-Villalenguas, Angel Lanas Arbeloa
Gastroenterologia Y Hepatologia|November 26, 2009
[Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study]Angel Lanas, Maria Muñoz, Maria Caballero Correa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 22, 2015
Reply: To PMID 25460554Angel Lanas, Patricia Carrera, Luis Bujanda, et al.
European Journal of Gastroenterology & Hepatology|February 1, 2003
Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugsAngel Lanas, Pedro Serrano, Eduardo Bajador, et al.
Expert Review of Clinical Pharmacology|November 26, 2011
Managing the adverse effects of nonsteroidal anti-inflammatory drugsPaola Patrignani, Stefania Tacconelli, Annalisa Bruno, et al.
The Journal of Pharmacy and Pharmacology|December 15, 2017
Differing disintegration and dissolution rates, pharmacokinetic profiles and gastrointestinal tolerability of over the counter ibuprofen formulationsIngvar Bjarnason, Ozgur Sancak, Anne Crossley, et al.
Pageof 27